Evidence map›Paper›PMID 41809735›Full record

ArticleInternational journal of cardiology. Cardiovascular risk and prevention2026

Toward practical screening of mortality risk: Insights from interpretable machine learning in NHANES.

Yi-Ting Lin, Lian-Yu Lin, Kai-Jen Chuang

Abstract read
In one paragraph

Article in International journal of cardiology. Cardiovascular risk and prevention, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yi-Ting LinDepartment of Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Lian-Yu LinDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Kai-Jen ChuangDepartment of Public Health, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Efficient community-based screening for individuals at high risk of mortality is a major public health challenge. While many predictors have been proposed, there is limited consensus on which factors are both robust and practical for population screening. This study applied interpretable machine learning to identify efficient predictors of all-cause and cardiovascular mortality in a nationally representative cohort. Methods: We analyzed 9957 adults aged ≥40 years from NHANES 1999-2004 with linked mortality follow-up. A total of 134 demographic, lifestyle, and biomarker variables were evaluated across multiple algorithms. Model interpretability was assessed with Shapley Additive Explanations (SHAP), and the prognostic implications of leading predictors were examined with Kaplan-Meier analyses. Results: Over 5 years, 1293 participants (13.0%) died. Across analytic approaches, age, troponin T (TNT), and N-terminal pro-B type natriuretic peptide (NT-proBNP) consistently emerged as the most influential predictors. Survival analyses demonstrated significantly poorer outcomes among individuals with elevated TNT and NT-proBNP. A parsimonious five-variable model (age, TNT, NT-proBNP, physical activity, gender) retained good discrimination (AUC = 0.841) and calibration. Conclusions: A parsimonious set of five predictors-age, gender, physical activity, TNT, and NT-proBNP-enabled efficient mortality risk stratification in NHANES, supporting their potential role in practical community screening.

Indexed as

Machine learningMortalityNHANESN-terminal pro B-Type natriuretic peptideScreening mortalityTroponin T

Identifiers

PMID41809735
PMCPMC12969032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.